T.Man Pharmaceutical PCL (BKK:TMAN)

T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	502.43	399.31	348.39	348.04	307.17	22.19
Short-Term Investments	353.68	352.3	450	-	-	-
Cash & Short-Term Investments	856.12	751.62	798.39	348.04	307.17	22.19
Cash Growth	7.39%	-5.86%	129.40%	13.30%	1284.31%	-66.83%
Accounts Receivable	721.34	848.11	596.4	577.79	507.27	256.08
Other Receivables	104.61	189.97	20.57	38.75	21.37	23.94
Receivables	825.95	1,038	616.97	616.54	528.64	280.02
Inventory	738.91	612.66	541.45	481.82	357.96	308.9
Other Current Assets	3.01	3.15	3.51	4.99	32.2	4.21
Total Current Assets	2,424	2,406	1,960	1,451	1,226	615.32
Property, Plant & Equipment	1,237	1,204	1,143	1,048	930.41	742.63
Long-Term Investments	32.31	-	200	-	-	-
Other Intangible Assets	50.99	45.15	33.84	25.69	12.56	1.23
Long-Term Deferred Tax Assets	42.36	45.24	34.25	38.89	40.69	-
Other Long-Term Assets	83.31	83.71	84	63.18	68.24	199.02
Total Assets	3,870	3,784	3,456	2,627	2,278	1,558

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	536.29	507.62	380.62	331.91	333.08	192.3
Short-Term Debt	870	875	1,080	503.43	535	614.57
Current Portion of Long-Term Debt	-	-	-	33.08	22	16.01
Current Portion of Leases	5.8	5.17	5.66	7.08	4.55	3.01
Current Income Taxes Payable	33.95	54.74	27.53	22.63	110.2	11.34
Current Unearned Revenue	98.26	100.68	72.01	100.29	73.8	-
Other Current Liabilities	8.93	10.09	10.27	23.98	20.46	59.06
Total Current Liabilities	1,553	1,553	1,576	1,022	1,099	896.29
Long-Term Debt	-	-	-	-	33.08	8.33
Long-Term Leases	62.95	63.28	64.95	47.89	44.36	28.28
Pension & Post-Retirement Benefits	51.69	49.02	44.09	35.18	32.13	28.21
Other Long-Term Liabilities	1.2	1.1	0.58	2.39	26.93	25.89
Total Liabilities	1,669	1,667	1,686	1,108	1,236	987

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	300	300	300	246.43	187.3	187.3
Additional Paid-In Capital	1,394	1,394	1,394	305.88	305.88	305.88
Retained Earnings	759.09	674.88	327.82	993.46	575.48	103.91
Comprehensive Income & Other	-251.78	-251.78	-251.78	-26.37	-26.37	-24.95
Total Common Equity	2,201	2,117	1,770	1,519	1,042	572.14
Minority Interest	0	0	-0	0	0	-0.93
Shareholders' Equity	2,201	2,117	1,770	1,519	1,042	571.21
Total Liabilities & Equity	3,870	3,784	3,456	2,627	2,278	1,558

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	938.75	943.46	1,151	591.48	638.99	670.21
Net Cash (Debt)	-82.63	-191.84	-352.22	-243.44	-331.82	-648.02
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.21	-0.48	-1.03	-0.88	-1.33	-8.98
Filing Date Shares Outstanding	400	400	400	328.57	249.73	249.73
Total Common Shares Outstanding	400	400	400	328.57	249.73	249.73
Working Capital	870.76	852.2	384.21	428.98	126.89	-280.97
Book Value Per Share	5.50	5.29	4.42	4.62	4.17	2.29
Tangible Book Value	2,150	2,072	1,736	1,494	1,030	570.91
Tangible Book Value Per Share	5.38	5.18	4.34	4.55	4.12	2.29
Land	-	124.07	124.07	108.09	94.16	64.95
Buildings	-	1,166	1,104	1,014	897.56	713.66
Machinery	-	597.82	610.1	548.56	448.73	415.39
Construction In Progress	-	84.1	81.02	68.6	93.44	82.16

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error